AU2268099A - Dendritic polymer-saccharide conjugate, pharmaceuticals containing said conjugate, method for its production and use thereof - Google Patents

Dendritic polymer-saccharide conjugate, pharmaceuticals containing said conjugate, method for its production and use thereof

Info

Publication number
AU2268099A
AU2268099A AU22680/99A AU2268099A AU2268099A AU 2268099 A AU2268099 A AU 2268099A AU 22680/99 A AU22680/99 A AU 22680/99A AU 2268099 A AU2268099 A AU 2268099A AU 2268099 A AU2268099 A AU 2268099A
Authority
AU
Australia
Prior art keywords
conjugate
production
dendritic polymer
pharmaceuticals containing
saccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22680/99A
Inventor
Dietmar Berndorff
Peter Mareski
Bernd Misselwitz
Johannes Dr. Platzek
Bernd Dr. Raduchel
Hanns-Joachim Weinmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2268099A publication Critical patent/AU2268099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/124—Macromolecular compounds dendrimers, dendrons, hyperbranched compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AU22680/99A 1997-12-18 1998-12-09 Dendritic polymer-saccharide conjugate, pharmaceuticals containing said conjugate, method for its production and use thereof Abandoned AU2268099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19758105 1997-12-18
DE19758105A DE19758105A1 (en) 1997-12-18 1997-12-18 New dendritic polymer-saccharide conjugates
PCT/EP1998/007927 WO1999032154A1 (en) 1997-12-18 1998-12-09 Dendritic polymer-saccharide conjugate, pharmaceuticals containing said conjugate, method for its production and use thereof

Publications (1)

Publication Number Publication Date
AU2268099A true AU2268099A (en) 1999-07-12

Family

ID=7853520

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22680/99A Abandoned AU2268099A (en) 1997-12-18 1998-12-09 Dendritic polymer-saccharide conjugate, pharmaceuticals containing said conjugate, method for its production and use thereof

Country Status (4)

Country Link
EP (1) EP1037672A1 (en)
AU (1) AU2268099A (en)
DE (1) DE19758105A1 (en)
WO (1) WO1999032154A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1210125A2 (en) * 1999-09-08 2002-06-05 INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN L-selectin contrast agents
DE10040381C1 (en) * 2000-08-11 2002-06-06 Schering Ag Perfluoroalkyl-containing complexes with sugar residues, process for their preparation and their use
US6641797B2 (en) 2000-08-11 2003-11-04 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
EP1507804B1 (en) * 2002-05-08 2008-01-30 Medical Enzymes AG Active carbohydrate containing protecting reagents for chemical modifications, their production and use
WO2009005353A1 (en) * 2007-07-02 2009-01-08 Erasmus University Medical Center Rotterdam High binding oligosaccharide compounds, compositions and uses thereof
CN108070090A (en) * 2016-11-14 2018-05-25 中国科学院大连化学物理研究所 A kind of sugar-metal coordinating polymer material and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA951877B (en) * 1994-03-07 1996-09-09 Dow Chemical Co Bioactive and/or targeted dendrimer conjugates
DE4425857A1 (en) * 1994-07-07 1996-01-11 Schering Ag Cascade polymer complexes, processes for their preparation and pharmaceutical compositions containing them
DE19525924A1 (en) * 1995-07-04 1997-01-09 Schering Ag Cascade polymer complexes, processes for their preparation and pharmaceutical compositions containing them
DE19549286A1 (en) * 1995-12-22 1997-06-26 Schering Ag Cascade polymer complexes, processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO1999032154A1 (en) 1999-07-01
EP1037672A1 (en) 2000-09-27
DE19758105A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
AU3373599A (en) Method, and system for product configuration
AU721035C (en) Modified aminoacids, pharmaceuticals containing these compounds and method for their production
AU4048299A (en) Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
AU2856499A (en) Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same
AU2310795A (en) Novel erythromycin derivatives, method for preparing same and use thereof as drugs
HUP9601652A1 (en) Piridyl-naphthalene derivatives, process for the preparation thereof, and intermediates thereof
AU1929897A (en) Novel erythromycin derivatives, method for preparing same, and use thereof as drugs
AU7029498A (en) Deformation element, method for its production and its use
AU6824298A (en) Oligosaccharides and the derivatives thereof, chemo-enzymatic method for the production thereof
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
AU7961200A (en) Urea derivative, process for producing the same, and medicine containing the urea derivative
AU9184998A (en) Processes for producing n,n-dialkylallylamine polymers and n,n-dialkylallylaminepolymers
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
AU6732598A (en) A biocompatible composition, methods for its preparation and uses thereof
HK1010885A1 (en) 10,13,15-trioxatricyclo [9.2.1.1.9.6]-pentadecanone-derivatives, process for their preparation and pharmaceutical containing them
AU1875199A (en) Safety system and device, as well as safety enhancing process appropriate therefor
AU2832899A (en) Hydroxyethyl starch conjugate, method for the production thereof and pharmaceuticals containing the same
AU2268099A (en) Dendritic polymer-saccharide conjugate, pharmaceuticals containing said conjugate, method for its production and use thereof
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
AU4946896A (en) Novel bi-tryptaminic derivatives, preparation process and utilization as drugs
HUP9800472A3 (en) New benzoxazinedion derivatives, process for producing them and pharmaceutical copositions containing them
AU3820699A (en) Catalyst and process for its preparation
AU7676698A (en) Method for the production of a branched macromolecule, the branched macromolecule and uses thereof
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase